• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • English
    • Français
  • Canada
    • Répertoire du site Sandoz
Sandoz : A Novartis Division
  • Our Work
    • What We Do
    • Quality Generics
    • Biopharmaceuticals
    • Specialty Products
  • About Us
    • Who We Are
    • Corporate Responsibility
    • Doing Business Responsibly
    • Contact Us
    • Grants, Donations and Sponsorships
  • Products
    • Consumers
    • Patients
    • Healthcare Professionals
    • Patient Support Programs
  • News
    • Media Releases
    • Media Resource Center
    • Stay Up-To-Date
  • Careers
    • Available Positions
    • Diversity & Inclusion
    • Our Benefits
  • Sandoz-Connect Portal
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
  • Jump to Comments
Stories/Global Impact

A first in Canada: generic version of pirfenidone

Pirfenidone is indicated in the treatment for idiopathic pulmonary fibrosis in adults.

May 12, 2021

Sandoz Canada announced the launch of PrSandoz® Pirfenidone tablets, a generic equivalent to PrEsbriet® manufactured by hoffmann-La Roche. Pirfenidone is indicated in the treatment for idiopathic pulmonary fibrosis in adults. Sandoz is the first manufacturer to launch the generic version of PrEsbriet® in Canada, thereby helping to generate savings for patients and public and private drug insurance plan providers.

Mainly sold at the community pharmacy level, the 267 mg tablets are available in two different bottle sizes, 21 and 270 tablets. The 801 mg tablets are also available in a bottle of 90 tablets.

Healthcare professionals and patients treated with PrSandoz® Pirfenidone can now count on Sandoz Continum™ Patient Support Program for educational tools, reimbursement and financial assistance where permitted.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Global Impact

Novartis expands humanitarian efforts in Ukraine through donation of essential medicines

Global Impact

Sandoz Canada Completes Sale of Sterile Injectable Medicine Manufacturing Plant

Global Impact

Sandoz Canada launches PrSandoz® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to PrTecfidera*

You are here

  1. Home ›
  2. Global Impact ›

Sandoz Canada

  • Notre travail
  • Our Work
  • À propos de nous
  • About Us
  • Produits
  • Products
  • Nouvelles
  • News
  • Carrières
  • Careers
  • Contactez-nous
  • Contact Us
  • Nous trouver
  • Office Locations
  • Rester à jour
  • Stay up to date

Subscribe to Sandoz

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • RSS
  • Sandoz Site Directory
© 2023 Sandoz AG

This site is intended for an audience in Canada

  • Termes d'utilisation
  • Terms of Use
  • Politique sur la vie privée
  • Privacy Policy
  • Terms of Trade
  • Return Policy
  • Politique d'achat
  • Politique de retour
  • Cookie Settings